학술논문
Oral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study
Document Type
Author
Skallsjö, Kristina, 1976; von Bültzingslöwen, Inger, 1947; Hasséus, Bengt, 1955; Johansson, Jan-Erik, 1963; Öhman, Jenny; Raber-Durlacher, J. E.; Huysmans, Mcdnjm; Laheij, Amga; van Leeuwen, S. J. M.; Hovan, A. J.; Legert, K. G.; Nguyen, H. M.; Turk, P. J.; Rozema, F. R.; Blijlevens, N. M. A.; Brennan, M. T.
Source
Plos One. 18(5)
Subject
Language
English
ISSN
1932-6203
Abstract
Despite advances in transplant medicine, prevalence of complications after hematopoietic stem cell transplantation (HSCT) remains high. The impact of pre-HSCT oral health factors on the incidence and severity of complications post-HSCT is poorly understood. The aim of this prospective, observational study was to analyze oral health in patients planned for HSCT. Patients >= 18 years requiring HSCT were included from five sites between 2011-2018. General health, oral findings and patient-reported symptoms were registered in 272 patients. Oral symptoms around disease onset were reported by 43 patients (15.9%) and 153 patients (58.8%) reported oral complications during previous chemotherapy. One third of patients experienced oral symptoms at the oral examination before conditioning regimen and HSCT. In total, 124 (46.1%) patients had dental caries, 63 (29.0%) had >= one tooth with deep periodontal pockets, 147 (75.0%) had >= one tooth with bleeding on probing. Apical periodontitis was observed in almost 1/4 and partially impacted teeth in 17 (6.3%) patients. Oral mucosal lesions were observed in 84 patients (30.9%). A total of 45 (17.4%) of 259 patients had at least one acute issue to be managed prior to HSCT. In conclusion, oral symptoms and manifestations of oral disease were prevalent in patients planned for HSCT. The extent of oral and acute dental diseases calls for general oral screening of patients pre-HSCT.